Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: A comparison of descriptive characteristics.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Pío del Río Hortega and the discovery of the oligodendrocytes.
Clinical characteristics of intermediate uveitis in adult Turkish patients.
Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Serum NSE and multiple sclerosis.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
POEMS Syndrome in a Juvenile Initially Diagnosed as Treatment Resistant Chronic Inflammatory Demyelinating Polyneuropathy.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Superficial brain stimulation in multiple sclerosis.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Inflammatory Cytokines and Physical Activity in Multiple Sclerosis.
The pathological and physiological roles of IL-6 amplifier activation.
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.

Pages